Phase 4 Endometriosis Trial, Recruiting NCT06951802 Sponsor: Insel Gruppe AG, University Hospital Bern Condition: Endometriosis
Back to Endometriosis

Phase 4 Endometriosis Trial, Recruiting

NCT06951802
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with or are suspected to have endometriosis and are scheduled for surgery to treat it at Inselspital, Bern University Hospital in Switzerland
  • People aged 18 or older
  • People whose overall health falls within a low-to-moderate risk category for surgery (known as ASA physical status 1–3, which covers generally healthy people through to those with some serious but stable health conditions — confirm with trial site if unsure which category applies)
  • People who have given written consent to participate

Who may not be able to join:

  • People under 18 years of age
  • People whose overall health is considered very high risk for surgery (ASA physical status 4 or above)
  • People who have a significant heart rhythm problem called a high-grade atrioventricular block and do not have a pacemaker
  • People with severely low blood volume or an unusually slow heart rate
  • People with blood pressure that is not under control, whether too high or too low
  • People with liver disease
  • People with a known condition called malignant hyperthermia, which is a serious reaction to certain anaesthetic medications
  • People with an unstable heart condition or severe heart failure (classified as worse than NYHA stage III — confirm with trial site)
  • People who have had a heart attack in the 30 days before surgery
  • People with raised pressure inside the skull or inside the eyes
  • People with reduced nerve activity in the peripheral nervous system, or a known allergy or sensitivity to ketamine, propofol, or any of their ingredients
  • People who are pregnant
  • People who have declined to participate or have not given consent

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Christian Vetter, MD, Dep. of Anaesthesiology and Pain Medicine, Inselsptial Bern

Phone: +416343776

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Insel Gruppe AG, University Hospital Bern
Registry
ClinicalTrials.gov
Start date
3 December 2024
Est. completion
30 June 2025

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Total opioids prescribed and consumed during hospitalization for endometriosis.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov